Vesicare and Drug ineffective - a phase IV clinical study of FDA data
Drug ineffective is found among people who take Vesicare, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Vesicare and have Drug ineffective. It is created by eHealthMe based on reports of 28,723 people who have side effects when taking Vesicare from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
28,723 people reported to have side effects when taking Vesicare.
Among them, 4,111 people (14.31%) have Drug ineffective.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 29,501 Vesicare users for its effectiveness, alternative drugs and more.
What is Drug ineffective?
Drug ineffective is found to be associated with 4,622 drugs and 5,066 conditions by eHealthMe.
Number of Vesicare and Drug ineffective reports submitted per year:
Time on Vesicare when people have Drug ineffective *:
Gender of people who have Drug ineffective when taking Vesicare*:
Age of people who have Drug ineffective when taking Vesicare *:
Common drugs people take besides Vesicare *:
Common side effects people have besides Drug ineffective *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Vesicare and have Drug ineffective?Check whether Drug ineffective is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Drug ineffective and when was it recovered:
Expand to all the drugs that have ingredients of solifenacin succinate:
Alternative drugs to, pros and cons of Vesicare:
- Vesicare (29,501 reports)
Common Vesicare side effects:
- Drug ineffective: 4,111 reports
- Constipation: 1,888 reports
- Fatigue (feeling of tiredness): 1,609 reports
- Dizziness: 1,265 reports
- Urinary tract infection: 1,160 reports
- Weakness: 1,122 reports
Browse all side effects of Vesicare:a b c d e f g h i j k l m n o p q r s t u v w x y z
Drug ineffective treatments and more:
- Drug ineffective (1,151,484 reports)
COVID vaccines that are related to Drug ineffective:
- Drug ineffective in Moderna COVID Vaccine
- Drug ineffective in Pfizer BioNTech Covid Vaccine
- Drug ineffective in Johnson and Johnson Covid Vaccine
Common drugs associated with Drug ineffective:
- Methotrexate: 104,668 reports
- Humira: 93,489 reports
- Enbrel: 90,931 reports
- Prednisone: 66,683 reports
- Xeljanz: 48,562 reports
- Orencia: 47,976 reports
- Adapalene: 45,683 reports
- Actemra: 40,430 reports
- Remicade: 37,128 reports
- Sulfasalazine: 35,158 reports
All the drugs that are associated with Drug ineffective:
- Drug ineffective (4,622 drugs)
Common conditions associated with Drug ineffective:
- Rheumatoid arthritis: 123,880 reports
- Pain: 40,150 reports
- Psoriasis: 33,532 reports
- High blood pressure: 31,954 reports
- Multiple sclerosis: 25,819 reports
- Depression: 24,053 reports
All the conditions that are associated with Drug ineffective:
- Drug ineffective (5,066 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on solifenacin succinate (the active ingredients of Vesicare) and Vesicare (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Loraz and Localised Intraabdominal Fluid Collection - 3 seconds ago
- Eliquis and Upper Gastrointestinal Haemorrhage - 4 seconds ago
- Macrobid and Basal Cell Carcinoma - 4 seconds ago
- Eliquis and Multiple Allergies - 10 seconds ago
- Methylphenidate Hydrochloride and Drug Withdrawal Syndrome - 11 seconds ago
- Ketamine Hcl and Actrapid drug interaction - 14 seconds ago
- Eliquis and Cardiac Arrest - 16 seconds ago
- Cymbalta and Polycystic Ovary Disease - 16 seconds ago
- Cymbalta and Polyfollicular Ovarian Disease - 16 seconds ago
- Cyclophosphamide and Mania Aggravated - 20 seconds ago